TY - JOUR AU - Dalakas, M. C. AU - Hohlfeld, R. PY - 2003 DA - 2003// TI - Polymyositis and dermatomyositis JO - Lancet VL - 362 UR - https://doi.org/10.1016/S0140-6736(03)14368-1 DO - 10.1016/S0140-6736(03)14368-1 ID - Dalakas2003 ER - TY - JOUR AU - Dalakas, M. C. PY - 2015 DA - 2015// TI - Inflammatory muscle diseases JO - N Engl J Med VL - 372 UR - https://doi.org/10.1056/NEJMra1402225 DO - 10.1056/NEJMra1402225 ID - Dalakas2015 ER - TY - JOUR AU - Bohan, A. AU - Peter, J. B. PY - 1975 DA - 1975// TI - Polymyositis and dermatomyositis (first of two parts) JO - N Engl J Med VL - 292 UR - https://doi.org/10.1056/NEJM197502132920706 DO - 10.1056/NEJM197502132920706 ID - Bohan1975 ER - TY - JOUR AU - Mastaglia, F. L. AU - Phillips, B. A. PY - 2002 DA - 2002// TI - Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria JO - Rheum Dis Clin North Am VL - 28 UR - https://doi.org/10.1016/S0889-857X(02)00021-2 DO - 10.1016/S0889-857X(02)00021-2 ID - Mastaglia2002 ER - TY - JOUR AU - Catalan, M. AU - Selva-O’Callaghan, A. AU - Grau, J. M. PY - 2014 DA - 2014// TI - Diagnosis and classification of sporadic inclusion body myositis (sIBM) JO - Autoimmun Rev VL - 13 UR - https://doi.org/10.1016/j.autrev.2014.01.016 DO - 10.1016/j.autrev.2014.01.016 ID - Catalan2014 ER - TY - JOUR AU - Mueller, C. AU - Liotta, L. A. AU - Espina, V. PY - 2010 DA - 2010// TI - Reverse phase protein microarrays advance to use in clinical trials JO - Mol Oncol VL - 4 UR - https://doi.org/10.1016/j.molonc.2010.09.003 DO - 10.1016/j.molonc.2010.09.003 ID - Mueller2010 ER - TY - JOUR AU - Tibes, R. AU - Qiu, Y. AU - Lu, Y. AU - Hennessy, B. AU - Andreeff, M. AU - Mills, G. B. PY - 2006 DA - 2006// TI - Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells JO - Mol Cancer Ther VL - 5 UR - https://doi.org/10.1158/1535-7163.MCT-06-0334 DO - 10.1158/1535-7163.MCT-06-0334 ID - Tibes2006 ER - TY - JOUR AU - Michaud, G. A. AU - Salcius, M. AU - Zhou, F. AU - Bangham, R. AU - Bonin, J. AU - Guo, H. PY - 2003 DA - 2003// TI - Analyzing antibody specificity with whole proteome microarrays JO - Nat Biotechnol VL - 21 UR - https://doi.org/10.1038/nbt910 DO - 10.1038/nbt910 ID - Michaud2003 ER - TY - JOUR AU - Strausberg, R. L. AU - Simpson, A. J. AU - Old, L. J. AU - Riggins, G. J. PY - 2004 DA - 2004// TI - Oncogenomics and the development of new cancer therapies JO - Nature VL - 429 UR - https://doi.org/10.1038/nature02627 DO - 10.1038/nature02627 ID - Strausberg2004 ER - TY - JOUR AU - Aldea, M. AU - Clofent, J. AU - Nunez de Arenas, C. AU - Chamorro, M. AU - Velasco, M. AU - Berrendero, J. R. PY - 2011 DA - 2011// TI - Reverse phase protein microarrays quantify and validate the bioenergetic signature as biomarker in colorectal cancer JO - Cancer Lett VL - 311 UR - https://doi.org/10.1016/j.canlet.2011.07.022 DO - 10.1016/j.canlet.2011.07.022 ID - Aldea2011 ER - TY - JOUR AU - Acebo, P. AU - Giner, D. AU - Calvo, P. AU - Blanco-Rivero, A. AU - Ortega, A. D. AU - Fernandez, P. L. PY - 2009 DA - 2009// TI - Cancer abolishes the tissue type-specific differences in the phenotype of energetic metabolism JO - Transl Oncol VL - 2 UR - https://doi.org/10.1593/tlo.09106 DO - 10.1593/tlo.09106 ID - Acebo2009 ER - TY - JOUR AU - Sanchez-Cenizo, L. AU - Formentini, L. AU - Aldea, M. AU - Ortega, A. D. AU - Garcia-Huerta, P. AU - Sanchez-Arago, M. PY - 2010 DA - 2010// TI - Up-regulation of the ATPase Inhibitory Factor 1 (IF1) of the mitochondrial H+-ATP synthase in human tumors mediates the metabolic shift of cancer cells to a Warburg phenotype JO - J Biol Chem VL - 285 UR - https://doi.org/10.1074/jbc.M110.146480 DO - 10.1074/jbc.M110.146480 ID - Sanchez-Cenizo2010 ER - TY - JOUR AU - Santacatterina, F. AU - Chamorro, M. AU - Nuñez de Arenas, C. AU - Navarro, C. AU - Martin, M. A. AU - Cuezva, J. M. PY - 2015 DA - 2015// TI - Quantitative analysis of proteins of metabolism by reverse phase protein microarrays identifies potential biomarkers of rare neuromuscular diseases JO - J Trans Med VL - 13 UR - https://doi.org/10.1186/s12967-015-0424-1 DO - 10.1186/s12967-015-0424-1 ID - Santacatterina2015 ER - TY - JOUR AU - Cuezva, J. M. AU - Ortega, A. D. AU - Willers, I. AU - Sanchez-Cenizo, L. AU - Aldea, M. AU - Sanchez-Arago, M. PY - 2009 DA - 2009// TI - The tumor suppressor function of mitochondria: translation into the clinics JO - Biochim Biophys Acta VL - 1792 UR - https://doi.org/10.1016/j.bbadis.2009.01.006 DO - 10.1016/j.bbadis.2009.01.006 ID - Cuezva2009 ER - TY - JOUR AU - Yizhak, K. AU - Devedec, S. E. AU - Rogkoti, V. M. AU - Baenke, F. AU - Boer, V. C. AU - Frezza, C. PY - 2014 DA - 2014// TI - A computational study of the Warburg effect identifies metabolic targets inhibiting cancer migration JO - Mol Syst Biol VL - 10 UR - https://doi.org/10.15252/msb.20145746 DO - 10.15252/msb.20145746 ID - Yizhak2014 ER - TY - JOUR AU - Selva, O. C. A. AU - Trallero, A. E. PY - 2008 DA - 2008// TI - Inflammatory myopathies. Dermatomyositis, polymyositis, and inclusion body myositis JO - Reumatol Clin VL - 4 UR - https://doi.org/10.1016/S1699-258X(08)72464-1 DO - 10.1016/S1699-258X(08)72464-1 ID - Selva2008 ER - TY - JOUR AU - Gunawardena, H. AU - Betteridge, Z. E. AU - McHugh, N. J. PY - 2009 DA - 2009// TI - Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression JO - Rheumatology (Oxford) VL - 48 UR - https://doi.org/10.1093/rheumatology/kep078 DO - 10.1093/rheumatology/kep078 ID - Gunawardena2009 ER - TY - JOUR AU - Benveniste, O. PY - 2015 DA - 2015// TI - Acquired inflammatory myopathies: interest of specific autoantibodies for their classification JO - Rev Prat VL - 65 ID - Benveniste2015 ER - TY - JOUR AU - Ledford, H. PY - 2014 DA - 2014// TI - Metabolic quirks yield tumour hope JO - Nature VL - 508 UR - https://doi.org/10.1038/508158a DO - 10.1038/508158a ID - Ledford2014 ER - TY - JOUR AU - Sereni, M. I. AU - Pierobon, M. AU - Angioli, R. AU - Petricoin, E. F. AU - Frederick, M. J. PY - 2013 DA - 2013// TI - Reverse phase protein microarrays and their utility in drug development JO - Methods Mol Biol VL - 986 UR - https://doi.org/10.1007/978-1-62703-311-4_13 DO - 10.1007/978-1-62703-311-4_13 ID - Sereni2013 ER - TY - JOUR AU - Dalakas, M. C. PY - 1991 DA - 1991// TI - Polymyositis, dermatomyositis and inclusion-body myositis JO - N Engl J Med VL - 325 UR - https://doi.org/10.1056/NEJM199111213252107 DO - 10.1056/NEJM199111213252107 ID - Dalakas1991 ER - TY - JOUR AU - Kooi, A. J. AU - Visser, M. PY - 2014 DA - 2014// TI - Idiopathic inflammatory myopathies JO - Handb Clin Neurol VL - 119 UR - https://doi.org/10.1016/B978-0-7020-4086-3.00032-1 DO - 10.1016/B978-0-7020-4086-3.00032-1 ID - Kooi2014 ER - TY - JOUR AU - Parker, K. C. AU - Kong, S. W. AU - Walsh, R. J. AU - Salajegheh, M. AU - Moghadaszadeh, B. PY - 2009 DA - 2009// TI - Fast-twitch sarcomeric and glycolytic enzyme protein loss in inclusion body myositis JO - Muscle Nerve VL - 39 UR - https://doi.org/10.1002/mus.21230 DO - 10.1002/mus.21230 ID - Parker2009 ER - TY - JOUR AU - Sigurgeirsson, B. AU - Lindelof, B. AU - Edhag, O. AU - Allander, E. PY - 1992 DA - 1992// TI - Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study JO - N Engl J Med VL - 326 UR - https://doi.org/10.1056/NEJM199202063260602 DO - 10.1056/NEJM199202063260602 ID - Sigurgeirsson1992 ER - TY - JOUR AU - Hill, C. L. AU - Zhang, Y. AU - Sigurgeirsson, B. AU - Pukkala, E. AU - Mellemkjaer, L. AU - Airio, A. PY - 2001 DA - 2001// TI - Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study JO - Lancet VL - 357 UR - https://doi.org/10.1016/S0140-6736(00)03540-6 DO - 10.1016/S0140-6736(00)03540-6 ID - Hill2001 ER - TY - JOUR AU - Chen, Y. J. AU - Wu, C. Y. AU - Huang, Y. L. AU - Wang, C. B. AU - Shen, J. L. AU - Chang, Y. T. PY - 2010 DA - 2010// TI - Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan JO - Arthritis Res Ther VL - 12 UR - https://doi.org/10.1186/ar2987 DO - 10.1186/ar2987 ID - Chen2010 ER - TY - JOUR AU - Vander Heiden, M. G. AU - Cantley, L. C. AU - Thompson, C. B. PY - 2009 DA - 2009// TI - Understanding the Warburg effect: the metabolic requirements of cell proliferation JO - Science VL - 324 UR - https://doi.org/10.1126/science.1160809 DO - 10.1126/science.1160809 ID - Vander Heiden2009 ER - TY - JOUR AU - Robinson, J. L. AU - Rose, I. A. PY - 1972 DA - 1972// TI - The proton transfer reactions of muscle pyruvate kinase JO - J Biol Chem VL - 247 ID - Robinson1972 ER - TY - JOUR AU - Tsutsumi, H. AU - Tani, K. AU - Fujii, H. AU - Miwa, S. PY - 1988 DA - 1988// TI - Expression of L- and M-type pyruvate kinase in human tissues JO - Genomics VL - 2 UR - https://doi.org/10.1016/0888-7543(88)90112-7 DO - 10.1016/0888-7543(88)90112-7 ID - Tsutsumi1988 ER - TY - JOUR AU - Mazurek, S. PY - 2011 DA - 2011// TI - Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells JO - Int J Biochem Cell Biol VL - 43 UR - https://doi.org/10.1016/j.biocel.2010.02.005 DO - 10.1016/j.biocel.2010.02.005 ID - Mazurek2011 ER - TY - JOUR AU - Anastasiou, D. AU - Yu, Y. AU - Israelsen, W. J. AU - Jiang, J. K. AU - Boxer, M. B. AU - Hong, B. S. PY - 2012 DA - 2012// TI - Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis JO - Nat Chem Biol VL - 8 UR - https://doi.org/10.1038/nchembio.1060 DO - 10.1038/nchembio.1060 ID - Anastasiou2012 ER - TY - JOUR AU - DeLaBarre, B. AU - Hurov, J. AU - Cianchetta, G. AU - Murray, S. AU - Dang, L. PY - 2014 DA - 2014// TI - Action at a distance: allostery and the development of drugs to target cancer cell metabolism JO - Chem Biol VL - 21 UR - https://doi.org/10.1016/j.chembiol.2014.08.007 DO - 10.1016/j.chembiol.2014.08.007 ID - DeLaBarre2014 ER - TY - JOUR AU - Hitosugi, T. AU - Kang, S. AU - Vander Heiden, M. G. AU - Chung, T. W. AU - Elf, S. AU - Lythgoe, K. PY - 2009 DA - 2009// TI - Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth JO - Sci Signal VL - 2 UR - https://doi.org/10.1126/scisignal.2000431 DO - 10.1126/scisignal.2000431 ID - Hitosugi2009 ER - TY - JOUR AU - Iqbal, M. A. AU - Gupta, V. AU - Gopinath, P. AU - Mazurek, S. AU - Bamezai, R. N. PY - 2014 DA - 2014// TI - Pyruvate kinase M2 and cancer: an updated assessment JO - FEBS Lett VL - 588 UR - https://doi.org/10.1016/j.febslet.2014.04.011 DO - 10.1016/j.febslet.2014.04.011 ID - Iqbal2014 ER - TY - JOUR AU - Wang, H. J. AU - Hsieh, Y. J. AU - Cheng, W. C. AU - Lin, C. P. AU - Lin, Y. S. AU - Yang, S. F. PY - 2014 DA - 2014// TI - JMJD5 regulates PKM2 nuclear translocation and reprograms HIF-1alpha-mediated glucose metabolism JO - Proc Natl Acad Sci USA VL - 111 UR - https://doi.org/10.1073/pnas.1311249111 DO - 10.1073/pnas.1311249111 ID - Wang2014 ER - TY - JOUR AU - Luo, W. AU - Hu, H. AU - Chang, R. AU - Zhong, J. AU - Knabel, M. AU - O’Meally, R. PY - 2011 DA - 2011// TI - Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1 JO - Cell VL - 145 UR - https://doi.org/10.1016/j.cell.2011.03.054 DO - 10.1016/j.cell.2011.03.054 ID - Luo2011 ER - TY - JOUR AU - Yang, W. AU - Xia, Y. AU - Ji, H. AU - Zheng, Y. AU - Liang, J. AU - Huang, W. PY - 2011 DA - 2011// TI - Nuclear PKM2 regulates beta-catenin transactivation upon EGFR activation JO - Nature VL - 480 UR - https://doi.org/10.1038/nature10598 DO - 10.1038/nature10598 ID - Yang2011 ER - TY - JOUR AU - Sanchez-Arago, M. AU - Formentini, L. AU - Martinez-Reyes, I. AU - Garcia-Bermudez, J. AU - Santacatterina, F. AU - Sanchez-Cenizo, L. PY - 2013 DA - 2013// TI - Expression, regulation and clinical relevance of the ATPase Inhibitory Factor 1 in human cancers JO - Oncogenesis VL - 2 UR - https://doi.org/10.1038/oncsis.2013.9 DO - 10.1038/oncsis.2013.9 ID - Sanchez-Arago2013 ER - TY - JOUR AU - Formentini, L. AU - Sánchez-Aragó, M. AU - Sánchez-Cenizo, L. AU - Cuezva, J. M. PY - 2012 DA - 2012// TI - The mitochondrial ATPase Inhibitory Factor 1 (IF1) triggers a ROS-mediated retrograde pro-survival and proliferative response JO - Mol Cell VL - 45 UR - https://doi.org/10.1016/j.molcel.2012.01.008 DO - 10.1016/j.molcel.2012.01.008 ID - Formentini2012 ER - TY - JOUR AU - Santacatterina, F. AU - Sanchez-Cenizo, L. AU - Formentini, L. AU - Mobasher, M. A. AU - Casas, E. AU - Rueda, C. B. PY - 2016 DA - 2016// TI - Down-regulation of oxidative phosphorylation in the liver by expression of the ATPase Inhibitory Factor 1 induces a tumor-promoter metabolic state JO - Oncotarget VL - 7 ID - Santacatterina2016 ER - TY - JOUR AU - Song, R. AU - Song, H. AU - Liang, Y. AU - Yin, D. AU - Zhang, H. AU - Zheng, T. PY - 2014 DA - 2014// TI - Reciprocal activation between ATPase Inhibitory Factor 1 and NF-kappaB drives hepatocellular carcinoma angiogenesis and metastasis JO - Hepatology VL - 60 UR - https://doi.org/10.1002/hep.27312 DO - 10.1002/hep.27312 ID - Song2014 ER - TY - JOUR AU - Wei, S. AU - Fukuhara, H. AU - Kawada, C. AU - Kurabayashi, A. AU - Furihata, M. AU - Ogura, S. PY - 2015 DA - 2015// TI - Silencing of ATPase Inhibitory Factor 1 inhibits cell growth via cell cycle arrest in bladder cancer JO - Pathobiology VL - 82 UR - https://doi.org/10.1159/000439027 DO - 10.1159/000439027 ID - Wei2015 ER - TY - JOUR AU - Yin, T. AU - Lu, L. AU - Xiong, Z. AU - Wei, S. AU - Cui, D. PY - 2015 DA - 2015// TI - ATPase Inhibitory Factor 1 is a prognostic marker and contributes to proliferation and invasion of human gastric cancer cells JO - Biomed Pharmacother VL - 70 UR - https://doi.org/10.1016/j.biopha.2014.12.036 DO - 10.1016/j.biopha.2014.12.036 ID - Yin2015 ER - TY - JOUR AU - Wu, J. AU - Shan, Q. AU - Li, P. AU - Wu, Y. AU - Xie, J. AU - Wang, X. PY - 2015 DA - 2015// TI - ATPase Inhibitory Factor 1 is a potential prognostic marker for the migration and invasion of glioma JO - Oncol Lett VL - 10 ID - Wu2015 ER - TY - JOUR AU - Garcia-Bermudez, J. AU - Cuezva, J. M. PY - 2016 DA - 2016// TI - The ATPase Inhibitory Factor 1 (IF1): a master regulator of energy metabolism and of cell survival JO - Biochim Biophys Acta VL - 1857 UR - https://doi.org/10.1016/j.bbabio.2016.02.004 DO - 10.1016/j.bbabio.2016.02.004 ID - Garcia-Bermudez2016 ER -